Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
2,528 rows where has_cryoEM = 0, has_known_aptamer = 0 and in_cev_map = 0 sorted by evidence_priority descending
This data as json, CSV (advanced)
surface_class 5
- B_cargo 1,406
- unknown 508
- A_surface 348
- A_assoc 146
- A2_pm_peripheral 120
in_cev_map 1
- - · 2,528 ✖
has_known_aptamer 1
- - · 2,528 ✖
has_cryoEM 1
- - · 2,528 ✖
has_activation_state_pdb_pair 1
- 0 2,528
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O95255 | ABCC6 | ATP-binding cassette sub-family C member 6 | Tier 1.5 | 0.809 | 1 | A_surface | 4 | 80.94 | 0 | 0 | 0 | 0 | 0 | Pseudoxanthoma elasticum | 0.864631668818611 | |||
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Tier 1.5 | 0.799 | 1 | A_surface | 1 | 84.19 | 0 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism | 0.83100005285263 | |||
| Q12866 | MERTK | Tyrosine-protein kinase Mer | Tier 1 | 0.79 | 1 | A_surface | 42 | 72.25 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7985580877708576 | |||
| P16871 | IL7R | Interleukin-7 receptor subunit alpha | Tier 1 | 0.789 | 1 | A_surface | 8 | 67.44 | 0 | 0 | 0 | 0 | 0 | immunodeficiency 104 | 0.7983119488718231 | |||
| O43525 | KCNQ3 | Potassium voltage-gated channel subfamily KQT member 3 | Tier 1.5 | 0.789 | 1 | A_surface | 1 | 56.72 | 0 | 0 | 0 | 0 | 0 | Benign familial neonatal seizures | 0.7961763561533409 | |||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.789 | 1 | A_surface | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | |||
| P15509 | CSF2RA | Granulocyte-macrophage colony-stimulating factor receptor subunit alpha | Tier 1 | 0.788 | 1 | A_surface | 2 | 82.0 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7922592394513138 | |||
| Q13698 | CACNA1S | Voltage-dependent L-type calcium channel subunit alpha-1S | Tier 1.5 | 0.786 | 1 | A_surface | 2 | 71.81 | 0 | 0 | 0 | 0 | 0 | hypokalemic periodic paralysis, type 1 | 0.7869997029542154 | |||
| Q9H251 | CDH23 | Cadherin-23 | Tier 1 | 0.781 | 1 | A_surface | 6 | 76.75 | 0 | 0 | 0 | 0 | 0 | Usher syndrome type 1 | 0.7713456285400272 | |||
| Q8TDI8 | TMC1 | Transmembrane channel-like protein 1 | Tier 1.5 | 0.781 | 1 | A_surface | 1 | 76.88 | 0 | 0 | 0 | 0 | 0 | autosomal recessive nonsyndromic hearing loss 7 | 0.7694318181814068 | |||
| P21579 | SYT1 | Synaptotagmin-1 | Tier 1 | 0.779 | 1 | A_surface | 24 | 81.81 | 0 | 0 | 0 | 0 | 0 | infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome | 0.7640586502824556 | |||
| Q9NUN7 | ACER3 | Alkaline ceramidase 3 | Tier 1.5 | 0.777 | 1 | A_surface | 2 | 93.19 | 0 | 0 | 0 | 0 | 0 | alkaline ceramidase 3 deficiency | 0.7575827142824458 | |||
| Q9Y6J6 | KCNE2 | Potassium voltage-gated channel subfamily E member 2 | Tier 1.5 | 0.772 | 1 | A_surface | 1 | 78.25 | 0 | 0 | 0 | 0 | 0 | Romano-Ward syndrome | 0.739531738338193 | |||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.77 | 1 | A_surface | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 | |||
| Q96E22 | NUS1 | Dehydrodolichyl diphosphate synthase complex subunit NUS1 | Tier 1 | 0.769 | 1 | A_surface | 9 | 82.0 | 0 | 0 | 0 | 0 | 0 | congenital disorder of glycosylation type I | 0.7309837554022756 | |||
| O00305 | CACNB4 | Voltage-dependent L-type calcium channel subunit beta-4 | Tier 1.5 | 0.757 | 1 | A_surface | 1 | 71.81 | 0 | 0 | 0 | 0 | 0 | episodic ataxia type 5 | 0.6883498385715039 | |||
| Q13002 | GRIK2 | Glutamate receptor ionotropic, kainate 2 | Tier 1.5 | 0.757 | 1 | A_surface | 2 | 83.56 | 0 | 0 | 0 | 0 | 0 | intellectual disability, autosomal recessive 6 | 0.6913183275248935 | |||
| Q9UL01 | DSE | Dermatan-sulfate epimerase | Tier 1.5 | 0.755 | 1 | A_surface | 1 | 86.56 | 0 | 0 | 0 | 0 | 0 | Ehlers-Danlos syndrome, musculocontractural type | 0.6849286764746361 | |||
| O43570 | CA12 | Carbonic anhydrase 12 | Tier 1 | 0.754 | 1 | A_surface | 40 | 87.81 | 0 | 0 | 0 | 0 | 0 | isolated hyperchlorhidrosis | 0.6794515382695604 | |||
| Q02223 | TNFRSF17 | Tumor necrosis factor receptor superfamily member 17 | Tier 1 | 0.753 | 1 | A_surface | 11 | 64.94 | 0 | 0 | 0 | 0 | 0 | multiple myeloma | 0.6779550435975632 | |||
| Q9NYG8 | KCNK4 | Potassium channel subfamily K member 4 | Tier 1 | 0.749 | 1 | A_surface | 12 | 78.69 | 0 | 0 | 0 | 0 | 0 | facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome | 0.6619991022563834 | |||
| Q13454 | TUSC3 | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 | Tier 1 | 0.743 | 1 | A_surface | 4 | 84.75 | 0 | 0 | 0 | 0 | 0 | autosomal recessive non-syndromic intellectual disability | 0.6445043495923901 | |||
| P29274 | ADORA2A | Adenosine receptor A2a | Tier 1 | 0.733 | 1 | A_surface | 99 | 80.38 | 0 | 0 | 0 | 0 | 0 | migraine disorder | 0.6090172565654923 | |||
| P40200 | CD96 | T-cell surface protein tactile | Tier 1 | 0.731 | 1 | A_surface | 1 | 64.94 | 0 | 0 | 0 | 0 | 0 | C syndrome | 0.6042901819592128 | |||
| O43613 | HCRTR1 | Orexin/Hypocretin receptor type 1 | Tier 1 | 0.729 | 1 | A_surface | 14 | 78.81 | 0 | 0 | 0 | 0 | 0 | insomnia | 0.5956659546129768 | |||
| Q15399 | TLR1 | Toll-like receptor 1 | Tier 1.5 | 0.729 | 1 | A_surface | 6 | 87.19 | 0 | 0 | 0 | 0 | 0 | asthma | 0.5956884825296496 | |||
| O95977 | S1PR4 | Sphingosine 1-phosphate receptor 4 | Tier 1 | 0.728 | 1 | A_surface | 1 | 78.38 | 0 | 0 | 0 | 0 | 0 | multiple sclerosis | 0.5929073972137342 | |||
| Q03721 | KCNC4 | Voltage-gated potassium channel KCNC4 | Tier 1 | 0.727 | 1 | A_surface | 3 | 67.56 | 0 | 0 | 0 | 0 | 0 | multiple sclerosis | 0.589760175843455 | |||
| Q15822 | CHRNA2 | Neuronal acetylcholine receptor subunit alpha-2 | Tier 1.5 | 0.727 | 1 | A_surface | 1 | 77.0 | 0 | 0 | 0 | 0 | 0 | autosomal dominant nocturnal frontal lobe epilepsy | 0.5887530831976572 | |||
| P14778 | IL1R1 | Interleukin-1 receptor type 1 | Tier 1 | 0.723 | 1 | A_surface | 5 | 83.88 | 0 | 0 | 0 | 0 | 0 | rheumatoid arthritis | 0.5782381219205998 | |||
| O75888 | TNFSF13 | Tumor necrosis factor ligand superfamily member 13 | Tier 1.5 | 0.723 | 1 | A_surface | 1 | 81.19 | 0 | 0 | 0 | 0 | 0 | IGA glomerulonephritis | 0.5756611141862813 | |||
| P16471 | PRLR | Prolactin receptor | Tier 1 | 0.722 | 1 | A_surface | 12 | 61.03 | 0 | 0 | 0 | 0 | 0 | familial hyperprolactinemia | 0.5718636087471152 | |||
| P08118 | MSMB | Beta-microseminoprotein | Tier 1 | 0.719 | 1 | A_surface | 2 | 88.5 | 0 | 0 | 0 | 0 | 0 | prostate carcinoma | 0.5635654550330756 | |||
| Q9Y2K2 | SIK3 | Serine/threonine-protein kinase SIK3 | Tier 1.5 | 0.717 | 1 | A_surface | 5 | 50.66 | 0 | 0 | 0 | 0 | 0 | Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia | 0.5576394742765879 | |||
| Q96F15 | GIMAP5 | GTPase IMAP family member 5 | Tier 1 | 0.713 | 1 | A_surface | 1 | 89.38 | 0 | 0 | 0 | 0 | 0 | portal hypertension, noncirrhotic, 2 | 0.5417675196265873 | |||
| Q68D85 | NCR3LG1 | Natural cytotoxicity triggering receptor 3 ligand 1 | Tier 1.5 | 0.712 | 1 | A_surface | 4 | 77.62 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.539257633627721 | |||
| Q9UPR3 | SMG5 | Nonsense-mediated mRNA decay factor SMG5 | Tier 1 | 0.709 | 1 | A_surface | 1 | 72.88 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5306868542359863 | |||
| Q16821 | PPP1R3A | Protein phosphatase 1 regulatory subunit 3A | Tier 1.5 | 0.708 | 1 | A_surface | 1 | 44.66 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.5280839677306426 | |||
| O00198 | HRK | Activator of apoptosis harakiri | Tier 1 | 0.707 | 1 | A_surface | 7 | 72.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5239869025305895 | |||
| Q01151 | CD83 | CD83 antigen | Tier 1.5 | 0.707 | 1 | A_surface | 4 | 72.56 | 0 | 0 | 0 | 0 | 0 | rheumatoid arthritis | 0.5217195398123413 | |||
| P49771 | FLT3LG | Fms-related tyrosine kinase 3 ligand | Tier 1 | 0.704 | 1 | A_surface | 6 | 81.31 | 0 | 0 | 0 | 0 | 0 | cancer | 0.5124806377727481 | |||
| Q8N6L0 | KASH5 | Protein KASH5 | Tier 1 | 0.7 | 1 | A_surface | 2 | 68.75 | 0 | 0 | 0 | 0 | 0 | spermatogenic failure 88 | 0.5013716202209835 | |||
| Q9NZK5 | ADA2 | Adenosine deaminase 2 | Tier 1 | 0.699 | 1 | A_assoc | 2 | 95.81 | 0 | 0 | 0 | 0 | 0 | deficiency of adenosine deaminase 2 | 0.8291292532404531 | |||
| Q99972 | MYOC | Myocilin | Tier 1 | 0.699 | 1 | A_assoc | 24 | 78.94 | 0 | 0 | 0 | 0 | 0 | glaucoma 1, open angle, A | 0.8294483747483756 | |||
| O95256 | IL18RAP | Interleukin-18 receptor accessory protein | Tier 1.5 | 0.698 | 1 | A_surface | 3 | 77.81 | 0 | 0 | 0 | 0 | 0 | asthma | 0.494046797330986 | |||
| Q9UBH0 | IL36RN | Interleukin-36 receptor antagonist protein | Tier 1 | 0.695 | 1 | A_assoc | 3 | 92.44 | 0 | 0 | 0 | 0 | 0 | psoriasis 14, pustular | 0.8155144873787125 | |||
| Q9Y2C9 | TLR6 | Toll-like receptor 6 | Tier 1.5 | 0.694 | 1 | A_surface | 1 | 85.81 | 0 | 0 | 0 | 0 | 0 | response to stimulus | 0.4801931545173786 | |||
| Q96MK3 | FAM20A | Pseudokinase FAM20A | Tier 1 | 0.693 | 1 | A_assoc | 4 | 85.25 | 0 | 0 | 0 | 0 | 0 | amelogenesis imperfecta type 1G | 0.8106031517056754 | |||
| A8MYU2 | KCNU1 | Potassium channel subfamily U member 1 | Tier 1.5 | 0.693 | 1 | A_surface | 1 | 74.25 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.47664025348421396 | |||
| P55000 | SLURP1 | Secreted Ly-6/uPAR-related protein 1 | Tier 1 | 0.692 | 1 | A_assoc | 2 | 84.19 | 0 | 0 | 0 | 0 | 0 | mal de Meleda | 0.8064330379723671 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;